GLNMX | RSEBX | GLNMX / RSEBX | |
Total Expense Ratio | 1.10 | 1.45 | 76% |
Annual Report Gross Expense Ratio | 1.56 | 1.45 | 108% |
Fund Existence | 14 years | 11 years | - |
Gain YTD | 11.452 | 9.281 | 123% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 76.8M | 79.8B | 0% |
Annual Yield % from dividends | 0.56 | 0.23 | 242% |
Returns for 1 year | 12.53 | 9.34 | 134% |
Returns for 3 years | 33.66 | 31.03 | 109% |
Returns for 5 years | 23.14 | 16.78 | 138% |
Returns for 10 years | 66.08 | 43.37 | 152% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GMVCX | 15.79 | 0.14 | +0.89% |
Goldman Sachs Small/Mid Cap Equity C | |||
SBQIX | 14.98 | 0.13 | +0.88% |
AmericaFirst Alpha Trends Factor Class I | |||
FSSZX | 38.56 | 0.32 | +0.84% |
Fidelity Advisor Stock Selector Sm Cp Z | |||
PJHRX | 30.45 | 0.15 | +0.50% |
PGIM Jennison Health Sciences R | |||
FGNCX | 12.59 | -0.01 | -0.08% |
Nuveen Global Infrastructure C |